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Angiograms from 238 consecutive patients who under-
went percutaneous transluminal coronary angioplasty at 
the Mayo Clinic were reviewed to determine the presence 
of intracoronary thrombus before dilation. Patients with 
previously occluded vessels and those receiving strep-
tokinase therapy were excluded. Intracoronary throm-
bus before dilation was present in 15 patients (6%); 
complete occlusion occurred in 11 (73 % ) of these during 
or immediately after dilation. None of these patients had 
angiographic evidence of major intimal dissection. In 
contrast, among the 223 patients in whom no intracor-
Percutaneous transluminal coronary angioplasty is now an 
established option in the management of selected patients 
with coronary artery disease. Although advances in catheter 
technology and increasing operator experience have resulted 
in improved success rates, dilation is still associated with 
serious complications or failure in a significant number of 
patients. 
Complete occlusion of a coronary artery is the most com-
mon serious complication related to angioplasty and is a 
frequent indication for emergency coronary artery bypass 
grafting (1-3). Although intracoronary thrombus is the most 
common cause of complete occlusion in some subsets of 
patients with coronary artery disease-for example, acute 
myocardial infarction (4-7)-the role that intracoronary 
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onary thrombus was present before dilation, complete 
occlusion occurred in 18 (8 %) and in 12 was associated 
with major intimal dissection. The difference between 
the complete occlusion rates for patients with and with-
out prior intracoronary thrombus was highly significant 
(73 versus 8%, respectively, p < 0.001). 
Therefore, the presence of intracoronary thrombus 
identifies a group of patients who are at increased risk 
of developing complete occlusion during or after at-
tempted coronary artery dilation. 
(J Am Coli CardioI1985;5:198-202) 
thrombus plays in acute occlusion during attempted dilation 
is unknown. The purpose of this study was to evaluate the 
role of preexisting intraluminal thrombus in the outcome of 
patients undergoing angioplasty. 
Methods 
General aspects. Study patients. Two hundred eighty-
four patients underwent coronary angioplasty at the Mayo 
Clinic from October 1979 through March 1983. Coronary 
angiograms obtained before dilation were available for re-
view in 279 of these patients. Forty-one patients who under-
went combined streptokinase therapy and angioplasty during 
acute myocardial infarction or who had previously occluded 
vessels were excluded. The angiograms from the remaining 
238 patients were reviewed and form the basis for this report. 
Coronary angiography. The presence or absence of in-
tracoronary thrombus before dilation was determined by 
consensus between two experienced angiographers who did 
not know the outcome of angioplasty. The angiographic 
criteria for intracoronary thrombus have been previously 
described and validated in surgical and pathologic speci-
mens (4-9). These criteria include I) the presence of an 
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intraluminal central filling defect or lucency surrounded by 
contrast material that is seen in multiple projections (Fig . 
I) . 2) absence of calcium within the defect, and 3) persis-
tence of contrast material within the lumen . Visible em-
bolization of intraluminal material downstream was also 
considered to be consistent with the presence of intracor-
onary thrombus. but was noted only infrequently. 
The angiographic criterion .f(JI' coronary dissection atier 
dilation was the presence of a large intimal flap with a double 
lumen contour or persistent staining of the wall of the vessel 
by contrast material. 
Clinical features. A detailed clinical profile for each 
patient was retrieved from the data bank of the Mayo Clinic 
cardiac laboratory . The definitions of unstable angina and 
variant angina were those used in the Percutaneous Trans-
luminal Coronary Angioplasty (PTCA) Registry of the Na-
tional Heart. Lung. and Blood Institute (I). Unstable angina 
was defined as new onset of exertional chest pain or new 
MABIN ET AL. 199 
INTRACORONARY THROMBUS 
Figure 1. A. Left anterior oblique view of right coronary artery . 
showing severe stenosis in the proximal region and a filling defect 
consi stenl with intracoronary thrombus immediately downstream 
(arrow). B. Right anterior oblique view documenting filling defect 
just distal to high grade stenosis (arrow). C. Angiogram taken 
during attempted dilation. After inilial success. total occlusion 
developed at the stenosis. with faint visualization of the distal 
vessel . 
onset of chest pain at rest or with minimal effort. or as an 
unexplained change in the pattern of stable angina pectoris. 
Selection criteria and procedural details. Criteria for 
selection of patients for angioplasty and details of the pro-
cedure have been described prev iously (3). These criteria 
include symptomatic myocardial ischemia with angio-
graphic lesions suitable for dilation in patients who are can-
didates for surgical revascularization. Steerable catheter sys-
tems were not routinely used during the time period of this 
study. AntiplateJet therapy with dipyridamole. 75 to 100 
mg three or four times a day. often in combination with 
aspirin . 325 mg three times a day , was initiated 24 hours 
before dilation unless clinically contraindicated or not fea-
sible . All patients received nitrates. calcium channel antag-
onists and 5.000 to 10.000 units of heparin intravenously 
for anticoagulation during the procedure. During the time 
period encompassed by this study. the use of protamine was 
variable. Early in our experience. in some patients the effect 
of heparin was routinely either partially or fully reversed 
with administration of protamine sulfate at the completion 
of the dilation procedure to facilitate catheter withdrawal 
and hemostasis at the catheter en try si te. However. in none 
of the patients with coronary thrombus was protamine ad-
ministered. A successful dilation was defined as yielding at 
least 40% improvement in preangioplasty luminal diameter 
and no requirement for coronary bypass surgery. 
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Table 1. Clinical Characteristics of 238 Patients Who Underwent Percutaneous Transluminal 
Coronary Angioplasty (PTCA) 
Angiogram Before PTCA 
Characteristic Thrombus No Thrombus 
No. of patients 15 223 
Mean age (range) (yr) 61 (47 to 73) 55 (31 to 78) 
Sex distribution: % male 93 74 
Mean duration of angina (mo) 18 18 
Unstable angina 9 (60%) 144 (65%) 
Variant angina 2 (13%) 22 (10%) 
History of prior myocardial infarction* 10 (67%) 61 (27%) 
Recent myocardial infarction ( < I molt 6 (40%) 30 (13%) 
Site of coronary artery lesion 
Left anterior descending II (73%) 126 (57%) 
Circumflex 1(7%) 26 (12%) 
Right 3 (20%) 65 (29%) 
Other 0 6 (3%) 
Mean % stenosis before PTCA 92 92 
Single vessel disease 12 (80%) 163 (72%) 
*For difference between groups, p < 0.01; t for difference between groups, p < 0.02. 
Statistical analysis. Statistical analysis was performed 
with the use of a Fisher exact test. Differences were con-
sidered to be significant when the probability (p) value was 
less than 0,05. 
Results 
Clinical features (Table 1). There were IS patients (6%) 
with intracoronary thrombus present before dilation, and 
223 patients (94%) in whom no thrombus was detected. Of 
the patients with preexistent thrombus there were 14 men 
and I woman with a mean age of 61 years (range 47 to 73). 
The mean duration of angina among these 15 patients was 
18 months (range 5 days to 72 months). Unstable angina 
was present in nine patients (60%) and variant angina in 
two patients (13%). Ten patients (67%) had a history of 
previous myocardial infarction, and in six patients (40%) 
the myocardial infarction had occurred within I month of 
attempted dilation. No patient had an evolving acute myo-
cardial infarction at the time of angioplasty. Two patients 
underwent dilation for unstable angina after subendocardial 
infarction, one at 3 days and one at 5 days after infarction. 
There were no significant differences between the pa-
tients with thrombus and those without thrombus before 
angioplasty in terms of age, mean duration of angina, un-
stable angina, variant angina, severity of stenosis, distri-
bution of disease and the number of diseased vessels. How-
ever, the two groups were significantly different regarding 
two important variables. In the patients with thrombus be-
fore dilation, there was a higher incidence of prior infarction 
(67 versus 27%, p < 0.01). Also, the patients with thrombus 
before dilation had a higher incidence of infarction within 
the I month before angioplasty (40 versus 13%, p < 0.02). 
The prior infarction was in the distribution of the vessel to 
be dilated in all ofthe patients with thrombus before dilation. 
Location of coronary thrombus. The coronary artery 
thrombus was in the left anterior descending artery in II 
patients (73%), the right coronary artery in 3 patients (20%) 
and the circumflex coronary artery in I patient (7%). The 
thrombus was seen at or immediately distal to the lesion to 
be dilated in all but one patient; in this patient, the thrombus 
was immediately proximal to the lesion. The average degree 
of stenosis before angioplasty was 92% (range 70 to 99). 
Outcome of dilation (Table 2). Complete occlusion re-
quiring emergency coronary artery bypass grafting occurred 
during or immediately after dilation in 11 (73%) of the 15 
patients with prior intracoronary thrombus. Ten of these 
occlusions occurred while the patient was still in the cath-
eterization laboratory and before completion of the proce-
dure; one occlusion occurred after the patient had been trans-
ferred to the postprocedure area. None of these II patients 
had received protamine. Occlusion occurred either during 
or within 4 hours after the procedure in 18 (8%) of the 223 
patients without prior thrombus (p < 0.00 I). 
Table 2. Relation Between Presence of Thrombus Before 
Angioplasty and Outcome of Dilation in 238 Patients 
Total patients 
Acute occlusion 
Thrombus 
15 
II (73%) 
*p < 0.001 for difference from 73%. 
Preangioplasty 
Angiogram 
No Thrombus 
223 
18 (8%)* 
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Total coronary occlusion was documented by angiog-
raphy in all patients. In each case, the occlusion was at or 
immediately adjacent to the stenosis and thrombus (Fig. 
I C). Major intimal dissection was not detected in any patient 
with preexisting intracoronary thrombus in whom occlusion 
occurred. Dilation was successful in four of the five patients 
with prior thrombus who did not have complete occlusion. 
In one patient, angioplasty was unsuccessful and medical 
management was continued. 
Discussion 
Data from the PTCA Registry have demonstrated that 
the success rate of dilation is modified by a number of factors 
including the patient's age, duration of angina and anatomic 
features such as site, severity and morphologic character-
istics of the lesion (1,2, 10, 11). There is less information 
available on factors that are associated with increased com-
plications of angioplasty. Total coronary occlusion is the 
most frequent serious complication related to dilation. Iden-
tification of factors associated with increased occlusion rates 
might be of great value in optimizing patient selection and 
developing treatment strategies for preventing this 
complication. 
Intracoronary thrombus: a risk factor for complete 
occlusion. In the patients presented here, we identified a 
risk marker associated with a high rate of occlusion during 
angioplasty. There was a strong correlation between the 
presence of intracoronary thrombus before dilation and the 
subsequent development of complete coronary artery oc-
clusion during or immediately after dilation. In patients with 
intracoronary thrombus before dilation, coronary occlusion 
occurred in 73% compared with 8% in patients without 
evidence of preexisting intracoronary thrombus. This as-
sociation with thrombus before dilation and coronary oc-
clusion during or after dilation has not been previously 
described. 
Mechanisms for coronary occlusion after angio-
plasty. There are several potential mechanisms for coro-
nary occlusion after attempted angioplasty. These include 
intracoronary thrombus, dislodgment of atheromatous or 
thrombotic material, coronary artery spasm and coronary 
artery dissection. The typical angiographic features of dis-
section were not seen in the patients with preexisting coro-
nary artery thrombus whose dilated arteries abruptly became 
occluded. Nitrates and calcium channel antagonists were 
routinely administered, and spasm was not identified. The 
absence of these two features in the patients with preexisting 
coronary artery thrombus who developed complete occlu-
sion during or shortly after the procedure leads us to believe 
that the mechanism of occlusion was propagation of the 
thrombus, although other mechanisms could be involved. 
This contrasts with patients without preexisting coronary 
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artery thrombus, in whom coronary occlusion was infre-
quent and usually the result of major intimal dissection. 
In addition to the multiple potential causes of occlusion 
after attempted percutaneous transluminal coronary angio-
plasty, it is important to remember that technical advances 
have occurred, making the technique safer and more suc-
cessful. Steerable angioplasty systems were not used rou-
tinely in the patients described here; none of the 15 patients 
with preexisting thrombus' had dilation attempted with a 
steerable system. Negotiating the stenosis or the thrombus 
with a steerable system might improve success and prevent 
occlusion. 
Factors contributing to development of intracoronary 
thrombus. Many reports (4-8, 12, 13) now document the 
importance of intraluminal thrombus in acute infarction and 
unstable angina. The high prevalence of recent myocardial 
infarction in our patients with thrombus before angioplasty 
is consistent with these reports. In fact, the intracoronary 
thrombus may have been present and may have been the 
cause of the recent infarction. The factors that contribute to 
the development of intracoronary thrombus and its pro-
gression to complete occlusion have been discussed but 
remain incompletely understood (14). In the patients pre-
sented here, balloon trauma to the vessel wall during dilation 
may have exposed collagen and tissue factors and may have 
actually accelerated the thrombotic process. The role of 
heparin in preventing occlusion remains to be determined. 
In the patients with preexisting coronary artery thrombus, 
the occlusion occurred while the patient was still receiving 
heparin in the catheterization laboratory. In addition, in 
experimental dilation models, platelet thrombus deposition 
occurred despite continuous heparin use (15,16). Finally, it 
is possible that preexisting thrombus per se is merely a 
marker for a hypercoagulable state (17) that results in more 
extensive propagation of thrombus to complete occlusion. 
Preventive measures before and during dilation. The 
optimal treatment for patients undergoing coronary angio-
plasty, especially those with intracoronary thrombus, re-
mains to be determined. In our patients with thrombus before 
angioplasty, routine premedication with dipyridamole com-
bined with heparin during the dilation did not prevent com-
plete occlusion from occurring either during dilation or within 
a short time after what appeared to be successful dilation. 
This is consistent with results in animal studies of anti-
thrombotic therapy (16). 
In light of this experience and that from animal studies 
(16), we have modified our angioplasty procedure. In all 
patients with preexisting coronary artery thrombus, we leave 
the arterial sheath in place and continue intravenous heparin 
infusion for 24 hours after dilation. In addition, if not al-
ready used before angioplasty, aspirin is added to the reg-
imen along with the resumption of the dipyridamole. This 
medication regimen has been shown to be effective in re-
II)
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ducing the platelet thrombus deposition (14,16,18,19) that 
may play an important role in these patients. Finally, steer-
able systems are routinely used, which may facilitate cross-
ing the stenosis and avoiding the thrombus. 
Other options, such as thrombolytic therapy either before 
or during the procedure, also may be considered when an-
gioplasty is to be performed in patients with intraluminal 
thrombus. Although we and others (20-22) use a combi-
nation of dilation and streptokinase therapy for thrombotic 
occlusion in the setting of acute myocardial infarction, our 
experience with this approach for thrombotic occlusion dur-
ing dilation in the absence of acute infarction is limited. 
Continued evaluation of the role of angioplasty in pa-
tients with coronary artery thromhus is required. This anal-
ysis must take into consideration changes in dilation tech-
niques, including use of steerable systems, increased operator 
experience and changing drug regimens. Unless these mod-
ifications result in a significant reduction in the incidence 
of occlusion in patients with preexisting coronary thrombus, 
consideration must be given to surgical treatment as the 
primary therapy. 
In summary, we have identified a small but important 
subset of patients with preexisting intracoronary thrombus 
who are at a significantly higher risk for the development 
of acute coronary occlusion during attempted dilation. In 
patients without preexisting intraluminal coronary throm-
bus, acute occlusion is infrequent and is usually the result 
of major intimal dissection. 
References 
I. Kent KM, Bentivoglio LG. Block Pc' et al. Percutaneous transluminal 
coronary angioplasty: report from the Registry of the National Heart. 
Lung. and Blood Institute. Am J Cardiol 1982;49:2011-20. 
2. Dorros G. Cowley MJ. Simpson J. et al. Percutaneous transluminal 
coronary angioplasty: report of complications from the National Heart. 
Lung. and Blood Institute PTCA Registry. Circulation 1983;67:723-
30. 
3. Vlietstra RE. Holmes DR Jr. Smith HC, Hartzler GO. Orszulak TA. 
Percutaneous transluminal coronary angioplasty: initial Mayo Clinic 
experience. Mayo Clin Proc 1981:50:287-93. 
4. DeWood MA. Spores J. Notske R. et al. Prevalence of total coronary 
occlusion during the early hours of transmural myocardial infarction. 
N Engl J Med 1980;303:897-902. 
5. Mandelkorn lB. Wolf NM. Singh S. et al. Intracoronary thrombus in 
nontransmural myocardial infarction and in unstable angina pectoris. 
Am J Cardiol 1983;52: 1-6. 
lACC Vol. 5. No.2 
February 1985: 198-202 
6. Rentrop P. Btanke H. Karsch KR. Kaiser H. Kiistering H. Leitz K. 
Selective intracoronary thrombolysis in acute myocardial infarction 
and unstaole angina pectoris. Circulation 1981 ;03:307-17. 
7. Swan HJC. Thromoolysis in acute evolving. myocardial infarction: a 
new potential for myocardial salvage (editorial). N Engl J Med 
1983;308: 1354-5. 
8. Holmes DR Jr. Hartzler GO. Smith HC, Fuster V. Coronary artery 
thrombosis in patients with unstaolc angina. Br Heart J 1981 ;45:411-
6. 
9. Levin DC, Fallon JT. Significance of the angiographic morphology 
of localized wronary stenoses: histopathologic correlations. Circula-
tion 1982;00:310-20. 
10. Cowley MJ. Vetrovec GW. Wolfgang TC. Efficacy of percutaneous 
transluminal coronary angioplasty: technique. patient selection. sal-
utary result,. limitations and complications. Am Heart J 1981:10 I :272-
80. 
II. Meier B. Gruent/ig AR. Hollman 1. Ischinger T. Bradford JM. Does 
length or eccentricity of coronary stenoses influence the outcome of 
transluminal dilatation') Circulation 1983;67:497-9. 
12. Bresnahan DR. Davis JL. Holmes DR. Smith HC. Angiographic in-
cidence and clinical correlates of intra-luminal coronary thrombus 
(abstr). Circulation 1983;68(suppl 1ll):1ll-255. 
13. Vetrovec GW. Cowley MJ. Overton H. Richardson DW. Intracoron-
ary thromous in syndromes of lInstaole myocardial ischemia. Am Heart 
J 1981:102:1202-8. 
14. ]-'uster V. Chcseoro JH. Antithromootic therapy: role of platelet-in-
hibitor drugs. I. Current concepts of thrombogenesis: role of platelets. 
Mayo Clin Proc 1981;56:102-12. 
15. Steele PM. Chcseoro JH. Lamb HB. Stanson A W. Badimon L. Fuster 
V. Natural history of balloon angioplasty in pigs: wall injury. platelet-
thromou, deposition and intimal hyperplasia (abstr). Circulation 1983; 
68(suppl 1ll):1ll-264. 
10. Steele PM. Chesebro JH. Stan son AW. Holmes DR. Badimon L. 
Fuster V. Balloon angioplasty: effect of platelet-inhibitor drugs on 
platelet-thrombus deposition in a pig model (abstr). J Am Coli Cardiol 
1984;3:500. 
17. Chesebro JH. Fustcr V. Pumphrey CWo Wentland B. Improvement 
of shortened platelet survival half-life from the carly to the late phase 
of myocardial infarction (abstr). Circulation 1981 ;64(suppl IV):IV-
I '}7. 
18. Cheseoro JH. Clements !P. Fuster V. et al. A platelet-inhibitor-drug 
trial in coronary-artery bypass operations: benefit of perioperative di-
pyridamole and aspirin therapy on carly postoperative vein-graft pa-
tency. N Engl J Med 1982;307:73-8. 
1<). Josa M. Lie Jr. Bianco RL. Kaye MP. Reduction of thrombosis in 
canine coronary bypass vein grafts with dipyridamole and aspirin. Am 
J Cardiol 1<)81;47:1248-54. 
20. Meyer J. Merx W. Schmitz H. et al. Percutaneous transluminal coro-
nary angioplasty immediately after intracoronary streptolysis of trans-
mural myocardial infarction. Circulation 1982;66:905-13. 
21. Serruys PW. Wijns W. Van Den Brand M. et al. Is transluminal 
coronary angioplasty mandatory after successful thrombolysis? Quan-
titative coronary angiographic study. Br Heart J 1983;50:257-65. 
22. Holmes DR Jr. Nishimura RA. Vlietstra RE. et al. Percutaneous 
transluminal coronary angioplasty (/'TCA) during evolving acute myo-
cardial infarction (abstr). J Am Coli Cardiol 1984;3:575. 
p ,
,
,
l
h c 6
h
:
h
cor
6
e
ts ;
tz
11): 11-25
1
h u h
Fu e h h
h
:
e h h
,
h s
11): 11-26
6 , ,
6
h e
e
19
h I ,
e
9
981;47:1
'!
(
